User profiles for Michael D. Green
Michael D. GreenAssistant Professor, University of Michigan Verified email at med.umich.edu Cited by 6367 |
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Metastasis is the primary cause of cancer mortality, and cancer frequently metastasizes to
the liver. It is not clear whether liver immune tolerance mechanisms contribute to cancer …
the liver. It is not clear whether liver immune tolerance mechanisms contribute to cancer …
[HTML][HTML] KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
…, JC Craig, H Ekberg, CA Garvey, MD Green… - Kidney international, 2010 - Elsevier
The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline
on the monitoring, management, and treatment of kidney transplant recipients is intended to …
on the monitoring, management, and treatment of kidney transplant recipients is intended to …
Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11
This article describes ferroptosis as a previously unappreciated mechanism of action for
radiotherapy. Further, it shows that ferroptosis is a novel point of synergy between …
radiotherapy. Further, it shows that ferroptosis is a novel point of synergy between …
Efficient generation of lung and airway epithelial cells from human pluripotent stem cells
The ability to generate lung and airway epithelial cells from human pluripotent stem cells (hPSCs)
would have applications in regenerative medicine, modeling of lung disease, drug …
would have applications in regenerative medicine, modeling of lung disease, drug …
[HTML][HTML] Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Programmed death-1 ligand (PD-L1, B7-H1) and programmed cell death protein 1 (PD-1)
pathway blockade is a promising therapy for treating cancer. However, the mechanistic …
pathway blockade is a promising therapy for treating cancer. However, the mechanistic …
[PDF][PDF] Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells
Two populations of Nkx2-1 + progenitors in the developing foregut endoderm give rise to the
entire postnatal lung and thyroid epithelium, but little is known about these cells because …
entire postnatal lung and thyroid epithelium, but little is known about these cells because …
Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells
Directed differentiation of human embryonic stem (hES) cells and human induced pluripotent
stem (hiPS) cells captures in vivo developmental pathways for specifying lineages in vitro, …
stem (hiPS) cells captures in vivo developmental pathways for specifying lineages in vitro, …
Counterfeit anti-infective drugs
PN Newton, MD Green, FM Fernández… - The Lancet infectious …, 2006 - thelancet.com
The production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised
problem that contributes to morbidity, mortality, and drug resistance, and leads …
problem that contributes to morbidity, mortality, and drug resistance, and leads …
Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer
JL Speyer, MD Green, E Kramer, M Rey… - … England Journal of …, 1988 - Mass Medical Soc
Studies in animals suggest that the bispiperazinedione ICRF-187 can prevent the development
of dose-related doxorubicin-induced cardiac toxicity. In a randomized trial in 92 women …
of dose-related doxorubicin-induced cardiac toxicity. In a randomized trial in 92 women …
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
JL Speyer, MD Green… - Journal of Clinical …, 1992 - ascopubs.org
PURPOSE To test potential protection by ICRF-187 against cumulative doxorubicin-dose-related
cardiac toxicity, we conducted a randomized clinical trial in 150 women with advanced …
cardiac toxicity, we conducted a randomized clinical trial in 150 women with advanced …